Evan Kearns - 23 Jan 2025 Form 4 Insider Report for Cogent Biosciences, Inc. (COGT)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	COGT	Stock Option (Right to Buy)	Award	$0	+230,000		$0	230,000	23 Jan 2025	Common Stock	230,000	$8.89	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	This stock option shall vest in equal monthly installments over a four year period.